OBJECTIVE: We report experience of HIVQUAL-T implementation in Thailand. DESIGN: Program evaluation. SETTING: Twelve government hospital clinics. PARTICIPANTS: People living with HIV/AIDS (PLHAs) aged ≥15 years with two or more visits to the hospitals during 2002-08. INTERVENTION: HIVQUAL-T is a process for HIV care performance measurement (PM) and quality improvement (QI). The program includes PM using a sample of eligible cases and establishment of a locally led QI infrastructure and process. PM indicators are based on Thai national HIV care guidelines. QI projects address needs identified through PM; regional workshops facilitate peer learning. Annual benchmarking with repeat measurement is used to monitor progress. MAIN OUTCOME MEASURE: Percentages of eligible cases receiving various HIV services. RESULTS: Across 12 participating hospitals, HIV care caseloads were 4855 in 2002 and 13 887 in 2008. On average, 10-15% of cases were included in the PM sample. Percentages of eligible cases receiving CD4 testing in 2002 and 2008, respectively, were 24 and 99% (P< 0.001); for ARV treatment, 100 and 90% (P= 0.74); for Pneumocystis jiroveci pneumonia prophylaxis, 94 and 93% (P= 0.95); for Papanicolau smear, 0 and 67% (P< 0.001); for syphilis screening, 0 and 94% (P< 0.001); and for tuberculosis screening, 24 and 99% (P< 0.01). PM results contributed to local QI projects and national policy changes. CONCLUSIONS: Hospitals participating in HIVQUAL-T significantly increased their performance in several fundamental areas of HIV care linked to health outcomes for PLHA. This model of PM-QI has improved clinical care and implementation of HIV guidelines in hospital-based clinics in Thailand.
OBJECTIVE: We report experience of HIVQUAL-T implementation in Thailand. DESIGN: Program evaluation. SETTING: Twelve government hospital clinics. PARTICIPANTS: People living with HIV/AIDS (PLHAs) aged ≥15 years with two or more visits to the hospitals during 2002-08. INTERVENTION: HIVQUAL-T is a process for HIV care performance measurement (PM) and quality improvement (QI). The program includes PM using a sample of eligible cases and establishment of a locally led QI infrastructure and process. PM indicators are based on Thai national HIV care guidelines. QI projects address needs identified through PM; regional workshops facilitate peer learning. Annual benchmarking with repeat measurement is used to monitor progress. MAIN OUTCOME MEASURE: Percentages of eligible cases receiving various HIV services. RESULTS: Across 12 participating hospitals, HIV care caseloads were 4855 in 2002 and 13 887 in 2008. On average, 10-15% of cases were included in the PM sample. Percentages of eligible cases receiving CD4 testing in 2002 and 2008, respectively, were 24 and 99% (P< 0.001); for ARV treatment, 100 and 90% (P= 0.74); for Pneumocystis jiroveci pneumonia prophylaxis, 94 and 93% (P= 0.95); for Papanicolau smear, 0 and 67% (P< 0.001); for syphilis screening, 0 and 94% (P< 0.001); and for tuberculosis screening, 24 and 99% (P< 0.01). PM results contributed to local QI projects and national policy changes. CONCLUSIONS: Hospitals participating in HIVQUAL-T significantly increased their performance in several fundamental areas of HIV care linked to health outcomes for PLHA. This model of PM-QI has improved clinical care and implementation of HIV guidelines in hospital-based clinics in Thailand.
Authors: Lisa A Cosimi; Huong V Dam; Thai Q Nguyen; Huyen T Ho; Phuong T Do; Duat N Duc; Huong T Nguyen; Bridget Gardner; Howard Libman; Todd Pollack; Lisa R Hirschhorn Journal: BMC Health Serv Res Date: 2015-07-17 Impact factor: 2.655
Authors: Emanuel Catumbela; Victor Certal; Alberto Freitas; Carlos Costa; António Sarmento; Altamiro da Costa Pereira Journal: BMC Health Serv Res Date: 2013-06-28 Impact factor: 2.655
Authors: Sally Hargreaves; Keiran Rustage; Laura B Nellums; Joshua E Bardfield; Bruce Agins; Pierre Barker; M Rashad Massoud; Nathan P Ford; Meg Doherty; Gillian Dougherty; Satvinder Singh Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: Bisola Ojikutu; Molly Higgins-Biddle; Dana Greeson; Benjamin R Phelps; Anouk Amzel; Emeka Okechukwu; Usman Kolapo; Howard Cabral; Ellen Cooper; Lisa R Hirschhorn Journal: PLoS One Date: 2014-07-30 Impact factor: 3.240
Authors: Stephanie Bjerrum; Frank Bonsu; Nii Nortey Hanson-Nortey; Ernest Kenu; Isik Somuncu Johansen; Aase Bengaard Andersen; Lars Bjerrum; Dorte Jarbøl; Anders Munck Journal: Glob Health Action Date: 2016-08-26 Impact factor: 2.640
Authors: Daniel J Ikeda; Apollo Basenero; Joseph Murungu; Margareth Jasmin; Maureen Inimah; Bruce D Agins Journal: J Clin Tuberc Other Mycobact Dis Date: 2019-08-07